SCHEMBL25546065

SCHEMBL25546065

CCCc1cc(C2=NN(C(=O)CCl)C(c3cccc(OC)c3OC)C2)ccc1Br

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ YAP1 P46937 2/20 0.69
▸ TEAD4 Q15561 2/20 0.69
▸ KDM4E B2RXH2 5/20 0.55
▸ MAPT P10636 3/20 0.55
▸ RECQL P46063 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ ALDH1A1 P00352 3/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ HTT P42858 1/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ TEAD2 Q15562 1/20 0.51
▸ MAOA P21397 7/20 0.49
▸ MAOB P27338 3/20 0.49
▸ POLB P06746 1/20 0.46
▸ RNF114 Q9Y508 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21392919 0.85 YAP1 (0.83) YAP1TEAD4KDM4EMAPTRECQL
SCHEMBL25542768 0.82 YAP1 (0.85) YAP1TEAD4KDM4EMAPTRECQL
SCHEMBL3312768 0.74 KDM4E (0.70) YAP1TEAD4KDM4EMAPTRECQL
SCHEMBL3312796 0.73 PKM (0.67) YAP1TEAD4KDM4EALDH1A1SMN1; SMN2
SCHEMBL21393070 0.73 YAP1 (0.69) YAP1TEAD4KDM4EMAPTRECQL
SCHEMBL3319323 0.73 KDM4E (0.71) YAP1TEAD4KDM4EMAPTRECQL
SCHEMBL23052172 0.71 POLB (0.76) YAP1TEAD4KDM4EMAPTRECQL
SCHEMBL23052397 0.71 POLB (0.76) YAP1TEAD4KDM4EMAPTRECQL
SCHEMBL25546052 0.71 RNF114 (0.59) YAP1TEAD4KDM4EMAPTRECQL
SCHEMBL14133936 0.70 KDM4E (0.76) YAP1TEAD4KDM4EMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 YAP1 1622/4885TEAD4 1748/4885KDM4E 3016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback